No registrations found.
ID
NL-OMON28644
Source
NTR
Brief title
LONGHEVA registry
Health condition
pulmonary embolism
deep vein thrombosis
venous thromboembolism
cancer
kanker
longembolie
diep veneuze trombose
veneuze trombo-embolie
Sponsors and support
Primary sponsor
:
University Medical Center Groningen
Source(s) of monetary or material Support
:
LEO Pharma
Intervention
Outcome measures
Primary outcome
recurrence of VTE
bleeding events
mortality
Secondary outcome
risk factors of recurrent VTE
Study design
baseline, 3, 6, 9, 12 months
Intervention
none
Public
Dept of Vascular Medicine - University Medical Center Groningen
IT Wilts
Hanzeplein 1
Groningen 9713 GZ
The Netherlands
+31503612943
examinethrombosis@umcg.nl
IT Wilts
Hanzeplein 1
Groningen 9713 GZ
The Netherlands
+31503612943
examinethrombosis@umcg.nl
Scientific
Dept of Vascular Medicine - University Medical Center Groningen
IT Wilts
Hanzeplein 1
Groningen 9713 GZ
The Netherlands
+31503612943
examinethrombosis@umcg.nl
IT Wilts
Hanzeplein 1
Groningen 9713 GZ
The Netherlands
+31503612943
examinethrombosis@umcg.nl
Inclusion criteria
Patients with cancer (excluding non-melanoma skin cancer)
Confirmed diagnosis of acute pulmonary embolism or deep venous thrombosis
Exclusion criteria
legal age limitations
Design
Study type
:
Observational non invasive
Intervention model
:
Other
Control
:
N/A , unknown
Recruitment
NL
Recruitment status
:
Pending
Start date (anticipated)
:
Enrollment
:
200
Type
:
Anticipated
Not applicable
Application type
:
Not applicable
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL5061 |
NTR-old | NTR5192 |
Other | UMCG research register : 201500480 |